Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
Aliment Pharmacol Ther. 2010 Feb 15;31(4):477-85. doi: 10.1111/j.1365-2036.2009.04197.x. Epub 2009 Nov 11.
Congenital chloride diarrhoea in a newborn is a medical emergency, requiring early diagnostics and treatment to prevent severe dehydration and infant mortality. While most of the 250 cases reported arise from Finland, Poland and Arab countries, single cases with this autosomal recessive disorder appear worldwide. Such congenital chloride diarrhoea rarity makes diagnosis difficult. Life-long salt substitution with NaCl and KCl stabilizes fluid, electrolyte and acid-base balance diagnosis. When properly treated, the long-term outcome is favourable.
To summarize data on congenital chloride diarrhoea diagnosis, pathophysiology and treatment, and to provide guidelines for both acute and long-term management of congenital chloride diarrhoea.
Data are based on MEDLINE search for 'chloride diarrhoea', in addition to clinical experience in the treatment of the largest known series of patients.
Treatment of congenital chloride diarrhoea involves (i) life-long salt substitution; (ii) management of acute dehydration and hypokalaemia during gastroenteritis or other infections; and (iii) recognition and treatment of other manifestations of the disease, such as intestinal inflammation, renal impairment and male subfertility.
This review summarizes data on congenital chloride diarrhoea and provides guidelines for treatment. After being a mostly paediatric problem, adult patients constitute a rare challenge for gastroenterologists worldwide.
新生儿先天性氯性腹泻是一种医疗急症,需要早期诊断和治疗,以防止严重脱水和婴儿死亡。尽管报告的 250 例病例大多来自芬兰、波兰和阿拉伯国家,但这种常染色体隐性遗传疾病在全球范围内也有单一病例报告。这种先天性氯性腹泻的罕见性使得诊断变得困难。终身用 NaCl 和 KCl 进行盐替代治疗可稳定液体、电解质和酸碱平衡诊断。如果得到适当治疗,长期预后良好。
总结先天性氯性腹泻的诊断、病理生理学和治疗数据,并为先天性氯性腹泻的急性和长期管理提供指导。
数据基于 MEDLINE 对“氯性腹泻”的搜索,此外还结合了对最大已知系列患者的治疗的临床经验。
先天性氯性腹泻的治疗包括(i)终身盐替代治疗;(ii)在胃肠炎或其他感染期间管理急性脱水和低钾血症;以及(iii)识别和治疗疾病的其他表现,如肠道炎症、肾功能损害和男性不育。
本综述总结了先天性氯性腹泻的数据,并提供了治疗指南。先天性氯性腹泻曾经主要是儿科问题,现在全球的胃肠病学家都面临着罕见的成年患者挑战。